TrialBMC neurology2017

Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study.

Orestes Santos-Morales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.